Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

5 results
Display

Which treatment modality should we choose for advanced hepatocellular carcinoma?

Kim DY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Polyvinyl Alcohol Embolization Adjuvant to Oily Chemoembolization in Advanced Hepatocellular Carcinoma with Arterioportal Shunts

Kim YJ, Lee HG, Park JM, Lim YS, Chung MH, Sung MS, Yoo WJ, Lim HW

OBJECTIVE: To assess the feasibility and safety of polyvinyl alcohol (PVA) embolization adjuvant to transarterial oily chemoembolization (P-TACE) in advanced hepatocellular carcinoma (HCC) with arterioportal shunts (APS). MATERIALS AND METHODS:...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Efficacy of Percutaneous Ethanol Injection Therapy in Korean with Hepatocellular Carcinoma

Kang HW, Kim YJ, Kim KM, Kang JM, Kim SH, Kim JH, Yoon WJ, Yoon JH, Yoon YB, Lee HS

  • KMID: 1066041
  • Korean J Gastroenterol.
  • 2003 Dec;42(6):502-509.
BACKGROUND/AIMS: Percutaneous ethanol injection therapy (PEIT) is widely used for the treatment of hepatocellular carcinoma (HCC). However, its long-term therapeutic efficacy is not verified in Korea, one of hepatitis...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on Superselective Chemoembolization

Ji SK, Cho YK, Ahn YS, Kim MY, Park YO, Kim JK, Kim WT

OBJECTIVE: While the prognostic factors of survival for patients with hepatocellular carcinoma (HCC) who underwent transarterial chemoembolization (TACE) are well known, the clinical significance of performing selective TACE for HCC...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Comparison of Patients With Hepatocellular Carcinoma Between A Short-term (Less Than 6 months) Survival Group and A Long-term (Over 24 Months) Survival Group After Treatment with Transcatheter Arterial Chemoembolization

Kang IK, Kim SW, Hahn SH, Cho SC, Gham CW, Lee DH

  • KMID: 1123169
  • Korean J Hepatol.
  • 2002 Jun;8(2):189-200.
BACKGROUND/AIM: Although hepatocellular carcinoma(HCC) shows poor prognosis, transcatheter hepatic arterial chemoembolization(TACE) can improve survival rate in some patient groups. This study investigated the synergy effect of the different clinical indices...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr